All Industries

Top Synthetic Biology Companies

46 Synthetic Biology companies, sorted by total funding raised.

Ginkgo BioworksIPO

Our mission is to make biology easier to engineer.

Boston, United States501–1000Automation, Diagnostics
Extension Round·$790.0M·May 2020
DNA Script

DNA Script develops the SYNTAX platform for enzymatic DNA synthesis, enabling labs to print high-...

Paris, France51–200Biotech, Synthetic Biology
Series C·$466.5M·Jan 2022
Opentrons

We make robots for biologists.

New York, United States201–500Biotech, Healthcare
Extension Round·$250.8M·Nov 2025
Molecular Assemblies

Biotechnology company developing fully enzymatic DNA synthesis with 99.9% incorporation efficiency.

United States51–200Biotech, Synthetic Biology
Venture Unknown·$135.1M·Apr 2025
Ansa Biotechnologies

Next-generation DNA synthesis using enzymes

Emeryville, United States51–200Biotech, Healthcare
Series B·$131.6M·Oct 2025
Bota Bio

Industrial synthetic biotechnology company developing bio-based manufacturing solutions for consu...

Hangzhou, China51–200Biotech, Synthetic Biology
Series B·$115.0M·Jul 2021
FabricNano

Synthetic biology company using cell-free biomanufacturing to create enzyme-based industrial prod...

London, United Kingdom1–10Biotech, Synthetic Biology
Series B·$62.5M·Sep 2022
ZBiotics

ZBiotics makes genetically engineered probiotics.

San Francisco, United States11–50Food & Beverage, Healthcare
Series A·$39.5M·Aug 2024
Lygos

Lygos engineers yeast to convert sugar into high-value industrial…

San Francisco, United States51–200Biotech, Climate Tech
Venture Unknown·$38.6M·Jan 2019
Living Carbon

Plants that capture and store more carbon.

Charleston, United States11–50Agtech, Biotech
Series B·$36.0M·Jan 2023
ACX

Next-generation biocides for sustainable agriculture at scale

New York, United States1–10Agtech, Biotech
Pre-seed·$15.5M·Oct 2024
Adaptyv

We're building fully automated labs for protein engineering

Lausanne, Switzerland11–50Drug Discovery, Healthcare
Seed·$10.8M·Jan 2024
Granza Bio

Advancing Therapeutic Delivery

San Francisco, United States1–10Biotech, Healthcare
Seed·$7.1M·Jul 2024
GC
Genome CompilerClosed

Market-Network for synthetic biology industry

IsraelBiotech, Marketplace
Seed·$6.0M·Apr 2016
LEAH Labs

Living therapies for pets first, and their people next

Minneapolis, United States1–10Drug Discovery, Healthcare
Grant·$5.8M·Aug 2025
Sensible Biotechnologies

Unlocking the next generation of mRNA medicines

Oxford, United Kingdom11–50Biotech, Healthcare
Pre-seed·$4.2M·Apr 2023
General Biological

Synthetic biology company developing sustainable bioproduction technology to replace petrochemica...

New Haven, United States1–10Biotech, Industrial Chemicals
Seed·$3.0M·Mar 2026
Abalone Bio

We discover antibody drugs others can't

Emeryville, United States11–50Drug Discovery, Healthcare
Seed·$2.0M·Aug 2020
Birch Biosciences

We recycle plastic using engineered enzymes

Portland, United States1–10Biotech, Climate Tech
Grant·$1.8M·Sep 2024
SL
Simmbion LLC

R&D company with 2 SBIR/STTR awards from National Science Foundation.

BALTIMORE, United States1–10Biotech, Drug Discovery
Funding undisclosed
Cisterna Biologics

High quality mRNA for therapeutic application

San Diego, United States1–10Biotech, Healthcare
Grant·$1.0M·Aug 2024
Eugit Therapeutics

Enabling Tissue Targeting of Therapies

San Carlos, United States1–10Biotech, Healthcare
Grant·$775K·Aug 2024
Kopra Bio

Genetically engineered viruses that teach your immune system to kill…

San Francisco, United States1–10Biotech, Healthcare
Grant·$600K·Jan 2025
SynPlexity

Printing DNA sequences that are longer and at a cheaper price point.

Eugene, United States1–10Artificial Intelligence, Biotech
Funding undisclosed
AminoAnalytica

Your biotech's first AI protein engineer

San Francisco, United States1–10Artificial Intelligence, Biotech
Seed·$500K·Jun 2024